Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit
David S. Hains(Indiana University – Purdue University Indianapolis), Florian Krammer(Semmelweis University), Aaron E. Carroll(Indiana University – Purdue University Indianapolis), Andrew L. Schwaderer(Riley Hospital for Children), Michelle C. Starr(Indiana University School of Medicine), Amy C. Wilson(Indiana University – Purdue University Indianapolis), Fatima Amanat(Icahn School of Medicine at Mount Sinai)
Cited by 79
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Advances in the development of influenza virus vaccines
|Nature Reviews Drug Discovery|2015|597